Norges Bank’s Organogenesis Holdings ORGO Stock Holding History

Norges Bank’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,097,600	Closed	-$5.69M	–	972
2025 Q4	$5.69M	Buy	+1,097,600	New	+$5.32M	﹤0.01%	1363
2025 Q3	–	Sell	-64,900	Closed	-$238K	–	1086
2025 Q2	$238K	Sell	64,900 -417,300	-87%	-$1.56M	﹤0.01%	1683
2025 Q1	$2.08M	Hold	482,200	–	–	﹤0.01%	1522
2024 Q4	$1.54M	Hold	482,200	–	–	﹤0.01%	1719
2024 Q3	$1.38M	Hold	482,200	–	–	﹤0.01%	1699
2024 Q2	$1.35M	Hold	482,200	–	–	﹤0.01%	1785
2024 Q1	$1.37M	Hold	482,200	–	–	﹤0.01%	1771
2023 Q4	$1.97M	Hold	482,200	–	–	﹤0.01%	1794
2023 Q3	$1.53M	Buy	+482,200	New	+$1.53M	﹤0.01%	1852
2022 Q2	–	Sell	-110,200	Closed	-$840K	–	2137
2022 Q1	$840K	Sell	110,200 -224,400	-67%	-$1.74M	﹤0.01%	2072
2021 Q4	$3.09M	Hold	334,600	–	–	﹤0.01%	1986
2021 Q3	$4.76M	Sell	334,600 -116,900	-26%	-$1.82M	﹤0.01%	1936
2021 Q2	$7.5M	Buy	+451,500	New	+$8.42M	﹤0.01%	1835

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Norges Bank's ORGO Position: Q1 2026 in Review

Norges Bank sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 1,097,600 shares — an estimated $5.69M sold.

Norges Bank first reported a position in ORGO in Q2 2021 and held it in 13 quarters. The position peaked at $7.5M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Norges Bank reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 1,097,600 Organogenesis Holdings shares in Q1 2026, an estimated $5.69M.
Norges Bank first reported a position in Organogenesis Holdings in Q2 2021 and held it in 13 quarters.
Norges Bank's Organogenesis Holdings position peaked at $7.5M in Q2 2021.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.